Emerging Learnings From Pre-Clinical Combinations of Tumor-Activated Cytokines With Other Immune-oncology Agents

Time: 11:00 am
day: Conference Day Two


  • Revealing the scientific rationale for using cytokines in combination
  • Addressing challenges in combining systemically active cytokines
  • Exploring Pre-clinical data supporting use of Xilio’s tumor-activated cytokines in combination with other IO agents